undamentalytics Newsletter

Manzi Jim P: insider trades

Director at Thermo Fisher Scientific. No open-market purchases and 19 sales not made under a pre-set plan, reported from March 4, 2010 to February 7, 2023.

What happened after Manzi Jim P’s sales?

After their sales, the shares moved +2.5% against the index over 12 months on average (a negative figure means selling was the right call); 58% trailed it.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

Trade by trade

Manzi Jim P: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 0 — — — — — — Not enough years
Purchases, 6 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the trade 0 — — — — — — Not enough years
Sales, 3 months after the report 19 +1.8% +2.7% 37% 13 1.15 0.27 No reliable evidence
Sales, 12 months after the report 19 +2.5% −2.5% 58% 13 1.14 0.28 No reliable evidence
Sales, 12 months after the trade 19 +1.7% −2.9% 58% 13 1.04 0.32 No reliable evidence

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
Thermo Fisher Scientific TMO —019March 4, 2010February 7, 2023

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
February 7, 2023February 3, 2023 TMO Sale $584,559 −8.8%−28.6%−26.0%
August 3, 2022August 1, 2022 TMO Sale $486,156 −7.6%−16.9%−17.2%
February 15, 2022February 14, 2022 TMO Sale $845,925 +10.6%+9.3%+5.4%
August 2, 2021July 30, 2021 TMO Sale $306,901 +13.7%+14.4%+14.4%
July 28, 2020July 24, 2020 TMO Sale $1,294,865 +15.2%−6.9%−9.0%
February 6, 2020February 5, 2020 TMO Sale $1,465,531 +13.6%+32.6%+29.2%
August 19, 2019August 15, 2019 TMO Sale $500,283 +1.0%+34.1%+31.1%
August 18, 2017August 17, 2017 TMO Sale $1,957,325 +2.7%+13.3%+14.0%
June 6, 2016June 3, 2016 TMO Sale $173,961 −5.0%−1.5%−2.5%
November 3, 2015November 2, 2015 TMO Sale $407,145 +1.3%+7.1%+6.5%
April 30, 2014April 29, 2014 TMO Sale $344,550 +2.8%−2.5%−2.9%
February 18, 2014February 13, 2014 TMO Sale $538,384 −8.8%−11.6%−12.5%
February 7, 2014February 6, 2014 TMO Sale $685,560 −6.0%−11.2%−8.5%
May 8, 2013May 7, 2013 TMO Sale $620,850 +5.6%+22.8%+21.7%
November 15, 2012November 13, 2012 TMO Sale $1,001,960 +8.4%+33.1%+30.4%
May 31, 2011May 27, 2011 TMO Sale $520,800 −7.0%−22.6%−22.7%
March 4, 2011March 3, 2011 TMO Sale $499,656 +11.4%−6.8%−5.0%
May 4, 2010April 30, 2010 TMO Sale $3,489,249 −14.3%−7.5%−8.6%
March 4, 2010March 3, 2010 TMO Sale $2,826,243 +6.2%−3.0%−5.3%

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Manzi Jim P traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.